Consort Medical plc Stock price

Equities

CSRT

GB0000946276

Medical Equipment, Supplies & Distribution

Delayed London S.E. 5-day change 1st Jan Change
- GBX -.--% Intraday chart for Consort Medical plc +0.50% -1.46%
Sales 2018 311M 393M Sales 2019 305M 385M Capitalization 453M 572M
Net income 2018 16M 20.2M Net income 2019 10M 12.62M EV / Sales 2018 2.2 x
Net Debt 2018 95.5M 121M Net Debt 2019 97.4M 123M EV / Sales 2019 1.8 x
P/E ratio 2018
36.7 x
P/E ratio 2019
43.5 x
Employees -
Yield 2018
1.75%
Yield 2019
2.32%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Corporate Officer/Principal 58 -
Corporate Officer/Principal 63 10-04-30
Members of the board TitleAgeSince
Director/Board Member 40 22-03-14
Director/Board Member 44 23-01-31
Director/Board Member 47 22-10-31
More insiders
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.
More about the company
  1. Stock
  2. Equities
  3. Stock Consort Medical plc - London S.E.